DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1CONCERTA
02 1COVERA-HS
03 1DITROPAN XL
04 1ENVARSUS XR
05 1EXALGO
06 1FELODIPINE
07 1GLIPIZIDE
08 1HYDROMORPHONE HYDROCHLORIDE
09 1INVEGA
10 4METHYLPHENIDATE HYDROCHLORIDE
11 1MORPHINE SULFATE
12 1OXYBUTYNIN CHLORIDE
13 1OXYCONTIN
14 4PALIPERIDONE
01 120552
02 120897
03 121121
04 121217
05 121999
06 122272
07 176159
08 178855
09 1202645
10 1204452
11 1205634
12 1206121
13 1206406
14 1206726
15 1208643
16 1210818
17 1211009
18 1212133
19 1212807
20 1213473
01 18No
02 2Yes
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 213473
Country : US
Patented : No
Drug : PALIPERIDONE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 202645
Country : US
Patented : No
Drug : HYDROMORPHONE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 212133
Country : US
Patented : No
Drug : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 211009
Country : US
Patented : No
Drug : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 210818
Country : US
Patented : No
Drug : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 206726
Country : US
Patented : No
Drug : PALIPERIDONE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 212807
Country : US
Patented : No
Drug : PALIPERIDONE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 204452
Country : US
Patented : No
Drug : CONCERTA
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 21121
Country : US
Patented : No
Drug : DITROPAN XL
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 20897
Country : US
Patented : No
